MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with G

Guanfacine

Guanfacine 1mg modified-release tablets

No stability information

Stability notes for Guanfacine 1mg modified-release tablets

There are no stability notes for this medicine.

Suppliers (5) of Guanfacine 1mg modified-release tablets
Guanfacine 1mg modified-release tablets (A A H Pharmaceuticals Ltd)
Guanfacine 1mg modified-release tablets (Accord-UK Ltd)
Guanfacine 1mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Guanfacine 1mg modified-release tablets (Neuraxpharm UK Ltd)
Intuniv 1mg modified-release tablets (Takeda UK Ltd)

Guanfacine 1mg tablets

No stability information

Stability notes for Guanfacine 1mg tablets

There are no stability notes for this medicine.

Suppliers

Guanfacine 1mg tablets (Special Order)
Tenex 1mg tablets (Imported (United States))

Guanfacine 2mg modified-release tablets

No stability information

Stability notes for Guanfacine 2mg modified-release tablets

There are no stability notes for this medicine.

Suppliers (5) of Guanfacine 2mg modified-release tablets
Guanfacine 2mg modified-release tablets (A A H Pharmaceuticals Ltd)
Guanfacine 2mg modified-release tablets (Accord-UK Ltd)
Guanfacine 2mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Guanfacine 2mg modified-release tablets (Neuraxpharm UK Ltd)
Intuniv 2mg modified-release tablets (Takeda UK Ltd)

Guanfacine 2mg tablets

No stability information

Stability notes for Guanfacine 2mg tablets

There are no stability notes for this medicine.

Supplier

Guanfacine 2mg tablets (Special Order)

Guanfacine 3mg modified-release tablets

No stability information

Stability notes for Guanfacine 3mg modified-release tablets

There are no stability notes for this medicine.

Suppliers (5) of Guanfacine 3mg modified-release tablets
Guanfacine 3mg modified-release tablets (A A H Pharmaceuticals Ltd)
Guanfacine 3mg modified-release tablets (Accord-UK Ltd)
Guanfacine 3mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Guanfacine 3mg modified-release tablets (Neuraxpharm UK Ltd)
Intuniv 3mg modified-release tablets (Takeda UK Ltd)

Guanfacine 4mg modified-release tablets

No stability information

Stability notes for Guanfacine 4mg modified-release tablets

There are no stability notes for this medicine.

Suppliers (5) of Guanfacine 4mg modified-release tablets
Guanfacine 4mg modified-release tablets (A A H Pharmaceuticals Ltd)
Guanfacine 4mg modified-release tablets (Accord-UK Ltd)
Guanfacine 4mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Guanfacine 4mg modified-release tablets (Neuraxpharm UK Ltd)
Intuniv 4mg modified-release tablets (Takeda UK Ltd)

Guanfacine 5mg modified-release tablets

No stability information

Stability notes for Guanfacine 5mg modified-release tablets

There are no stability notes for this medicine.

Suppliers

Guanfacine 5mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Guanfacine 5mg modified-release tablets (Neuraxpharm UK Ltd)

Guanfacine 6mg modified-release tablets

No stability information

Stability notes for Guanfacine 6mg modified-release tablets

There are no stability notes for this medicine.

Suppliers

Guanfacine 6mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Guanfacine 6mg modified-release tablets (Neuraxpharm UK Ltd)

Guanfacine 7mg modified-release tablets

No stability information

Stability notes for Guanfacine 7mg modified-release tablets

There are no stability notes for this medicine.

Suppliers

Guanfacine 7mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
Guanfacine 7mg modified-release tablets (Neuraxpharm UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.